OJGas  Vol.3 No.7 , November 2013
Hbs antigen, what prevalence among pregnant women in Morocco? Preliminary results of a prospective study conducted in Hospital University Hassan II, Fez
ABSTRACT

The chronic viral hepatitis B is a public health problem and remains a global challenge with 350 million carriers of HBs antigen (HBsAg). The prevalence of HBsAg varies from one country or continent to another. In France, it is estimated to be 0.5%. In Morocco, the data are rare but some studies have estimated the prevalence to be 2.5%. Our aim is to estimate the prevalence of HBsAg among women who have recently given birth at the maternity CHU Hassan II of Morocco Fez, and to describe the epidemiological profile and risk factors for infection. In pregnancy, infection with hepatitis B virus (HBV) is dominated by the risk of mother to child transmission (vertical transmission), which can be avoided by serovaccination of the newborn. The search for HBsAg should be performed in all pregnant women.

 


Cite this paper
Sedreddine, L. , Sekkat, M. , Ibrahimi, S. and Aqodad, N. (2013) Hbs antigen, what prevalence among pregnant women in Morocco? Preliminary results of a prospective study conducted in Hospital University Hassan II, Fez. Open Journal of Gastroenterology, 3, 311-313. doi: 10.4236/ojgas.2013.37054.
References
[1]   Haute Autorité de Santé (2009) Dépistage prénatal de l’hépatite virale B.

[2]   Pol, S. (2010) L’hépatite B demeure un problème de santé publique en France. Archives de Pédiatrie, 17, 1-5.
http://dx.doi.org/10.1016/S0929-693X(10)70007-5

[3]   Ezzikouri, S., et al. (2008) Genotype determination in Moroccan hepatitis B chronic carriers. Infection, Genetics and Evolution, 8, 306-312.
http://dx.doi.org/10.1016/j.meegid.2008.01.010

[4]   Back, Y. (2008) Hépatitevirale B etgrossesse. Gastroentérologie Clinique et Biologique, 32, S12-S19.

[5]   Collenberg, E., et al. (2006) Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. Journal of Medical Virology, 78, 683-692.
http://dx.doi.org/10.1002/jmv.20593

[6]   Menendez, C., et al. (1999) Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. Journal of Medical Virology, 58, 215-220.
http://dx.doi.org/10.1002/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K

[7]   Hannachi, N., et al. (2009) Hépatite virale B chez les femmes enceintes tunisiennes: Facteurs de risque et intérêt de l’étude de la réplication virale en cas d’antigène HBe négatif. Pathologie Biologie, 57, e43-e47.
http://dx.doi.org/10.1016/j.patbio.2008.04.017

[8]   Denis, F., et al. (1999) Dépistage de l’Ag HBs chez les femmes enceintes: Quel taux de couverture? Enquête en Haute-Vienne, 33.

[9]   Braillon, A., et al. (2010) Grossesse et hépatite B en Picardie: Tracabililité du dépistage et prévalence. Gynécologie Obstétrique & Fertilité, 38, 13-17.
http://dx.doi.org/10.1016/j.gyobfe.2009.11.002

[10]   Pol, S., et al. (2005) Virus de l’hépatite B (VHB) et grossesse. AFEF.

[11]   Recommandations de pratiques cliniques de l’EASL. Prise en charge de l’hépatite chronique B (2009) EASL clinical practice guidelines. Management of chronichepatitis B. Gastroentérologie Clinique et Biologique, 33, 539-554.

[12]   Yoshizawa, H. (2003) Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. Journal of Gastroenterology and Hepatology, 18, 943-949.
http://dx.doi.org/10.1046/j.1440-1746.2003.03092.x

[13]   Circulaire DGS/SD5C/DHOS/E2 no 2004-532 du 10 novembre 2004 relative au dépistage obligatoire au cours de la grossesse de l’antigène HBs du virus de l’hépatite B (VHB) et à la vaccination des nouveau-nés de femmes porteuses de l’antigène du virus de l’hépatite B NOR.

 
 
Top